Pediatric response to second-line antiretroviral therapy in South Africa.
Pediatric response to second-line antiretroviral therapy in South Africa.
复制标题
DOI:
10.1371/journal.pone.0049591
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Feeney ME
中科院分区:
文献类型:
--
作者:
Zanoni BC;Sunpath H;Feeney ME
With improved access to pediatric antiretroviral therapy (ART) in resource-limited settings, more children could experience first-line ART treatment failure. We performed a retrospective cohort analysis using electronic medical records from HIV-infected children who initiated ART at McCord Hospital's Sinikithemba Clinic in KwaZulu-Natal, South Africa, from August 2003 to December 2010. We analyzed all records from children who began second-line ART due to first-line treatment failure. We used logistic regression to compare viral outcomes in Protease Inhibitor (PI)-based versus Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-based second-line ART, controlling for time on first-line ART, sex, and whether HIV genotyping guided the regimen change. Of the 880 children who initiated ART during this time period, 80 (9.1%) switched to second-line ART due to therapeutic failure of first-line ART after a median of 95 weeks (IQR 65–147 weeks). Eight (10%) of the failures received NNRTI-based second-line ART, all of whom failed a PI-based first-line regimen. Seventy (87.5%) received PI-based second-line ART, all of whom failed a NNRTI-based first-line regimen. Two children (2.5%) received non-standard dual therapy as second-line ART. Six months after switching ART regimens, the viral suppression rate was significantly higher in the PI group (82%) than in the NNRTI group (29%; p = 0.003). Forty-one children (51%) were tested for genotypic resistance prior to switching to second-line ART. There was no significant difference in six month viral suppression (p = 0.38) between children with and without genotype testing. Conclusion: NNRTI-based second-line ART carries a high risk of virologic failure compared to PI-based second-line ART.
登录
查看更多内容
DOI:
10.1097/qai.0b013e3181cf4882
发表时间:
2010-08
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
Emmett SD;Cunningham CK;Mmbaga BT;Kinabo GD;Schimana W;Swai ME;Bartlett JA;Crump JA;Reddy EA
通讯作者:
Reddy EA
影响因子:
120.7
作者:
Coovadia, Ashraf;Abrams, Elaine J.;Kuhn, Louise
通讯作者:
Kuhn, Louise
影响因子:
158.5
作者:
Palumbo, Paul;Lindsey, Jane C.;Violari, Avy
通讯作者:
Violari, Avy
DOI:
10.1097/qai.0b013e3182060610
发表时间:
2011-03-01
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
Davies MA;Moultrie H;Eley B;Rabie H;Van Cutsem G;Giddy J;Wood R;Technau K;Keiser O;Egger M;Boulle A;International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration
通讯作者:
International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration
影响因子:
3.8
作者:
Blanche, Stephane;Bologna, Rosa;Spinosa-Guzman, Sabrina
通讯作者:
Spinosa-Guzman, Sabrina